Global health practitioners around the world are constantly involved in a struggle to ensure access to health care.
Part of that struggle has involved pushing pharmaceutical companies to expand access to their products. But it’s also vital that those products are delivered in ways that meet the needs of patients.
The decades-long HIV response can provide some examples on how to expand access to medicines, said Angeli Achrekar, deputy executive director of programs at UNAIDS, during a Devex event on the sidelines of the United Nations General Assembly meeting this week in New York City. Some 75% of all people living with HIV and AIDS — nearly 31 million people — have access to lifesaving medication, she said.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Sara Jervingsarajerving
Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
